54.10
price up icon8.90%   4.42
after-market Dopo l'orario di chiusura: 55.12 1.02 +1.89%
loading

Revolution Medicines Inc Borsa (RVMD) Ultime notizie

pulisher
05:03 AM

RVMD Stock Surge: Time to Reassess? - timothysykes.com

05:03 AM
pulisher
04:50 AM

Can Revolution Medicines Inc. stock beat market expectations this quarterMarket Volume Report & AI Powered Trade Plan Recommendations - Trung tâm Dự báo KTTV quốc gia

04:50 AM
pulisher
04:21 AM

The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. - Investor's Business Daily

04:21 AM
pulisher
01:34 AM

Is Revolution Medicines Inc. stock a bargain at current levelsLayoff News & Expert Approved Momentum Trade Ideas - newser.com

01:34 AM
pulisher
01:24 AM

Raymond James Raises Price Target for Revolution Medicines (RVMD) to $76 | RVMD Stock News - GuruFocus

01:24 AM
pulisher
01:08 AM

Stocks making the biggest moves midday: Oracle, AST SpaceMobile, Revolution Medicines and more - CNBC

01:08 AM
pulisher
12:54 PM

Revolution Medicines (RVMD) Stock Rises as Shares Surge 8.8% - GuruFocus

12:54 PM
pulisher
12:02 PM

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday - Benzinga

12:02 PM
pulisher
11:48 AM

What earnings revisions data tells us about Revolution Medicines Inc.Quarterly Market Review & Smart Allocation Stock Tips - newser.com

11:48 AM
pulisher
10:31 AM

Revolution Medicines (RVMD) Soars Over 11% in Stock Market Surge - GuruFocus

10:31 AM
pulisher
10:27 AM

Revolution Medicines price target raised to $80 from $78 at BofA - TipRanks

10:27 AM
pulisher
09:52 AM

Revolution Medicines stock surges after FDA grants priority voucher - Investing.com

09:52 AM
pulisher
09:22 AM

Revolution Medicines stock surges after FDA grants priority voucher By Investing.com - Investing.com Australia

09:22 AM
pulisher
09:21 AM

Wedbush Reiterates Outperform Rating for RVMD with $77 Price Tar - GuruFocus

09:21 AM
pulisher
08:03 AM

Revolution Medicines receives FDA priority voucher for daraxonrasib By Investing.com - Investing.com South Africa

08:03 AM
pulisher
07:45 AM

Revolution Medicines receives FDA priority voucher for daraxonrasib - Investing.com India

07:45 AM
pulisher
06:36 AM

Revolution Medicines Receives FDA Voucher for Daraxonrasib - TipRanks

06:36 AM
pulisher
05:07 AM

US FDA announces recipients of national priority vouchers - Reuters

05:07 AM
pulisher
04:49 AM

Revolution Medicines Says Daraxonrasib Granted Voucher Under FDA National Priority Pilot Program; Shares Up Pre-Bell - MarketScreener

04:49 AM
pulisher
03:54 AM

Promising Prospects for Revolution Medicines: Buy Rating Affirmed on Daraxonrasib’s CNPV Designation - TipRanks

03:54 AM
pulisher
01:29 AM

Revolution Medicines (RVMD) Receives FDA Voucher for Cancer Trea - GuruFocus

01:29 AM
pulisher
01:06 AM

Revolution Medicines awarded voucher for Daraxonrasib by FDA - TipRanks

01:06 AM
pulisher
12:00 PM

Revolution Medicines awarded FDA voucher tied to daraxonrasib - Stock Titan

12:00 PM
pulisher
Oct 16, 2025

Revolution Medicines Receives FDA Voucher for Daraxonrasib Under National Priority Voucher Pilot Program - Quiver Quantitative

Oct 16, 2025
pulisher
Oct 16, 2025

Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner's National Priority Voucher Pilot Program - The Manila Times

Oct 16, 2025
pulisher
Oct 16, 2025

Revolution Medicines Awarded CNPV Voucher for Daraxonrasib | RVMD Stock News - Stock Titan

Oct 16, 2025
pulisher
Oct 16, 2025

Revolution Medicines Awarded Voucher for Daraxonrasib - GlobeNewswire

Oct 16, 2025
pulisher
Oct 16, 2025

How Revolution Medicines Inc. stock performs in rising dollar environmentQuarterly Portfolio Review & High Return Trade Guides - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Revolution Medicines (RVMD) Receives New 'Buy' Rating from Stife - GuruFocus

Oct 16, 2025
pulisher
Oct 15, 2025

Revolution Medicines (RVMD) Positioned for Growth with Promising Market Potential - GuruFocus

Oct 15, 2025
pulisher
Oct 15, 2025

Using data filters to optimize entry into Revolution Medicines Inc. Equity Warrant2025 Top Gainers & Reliable Price Breakout Signals - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program - Stocktwits

Oct 15, 2025
pulisher
Oct 15, 2025

Is a relief rally coming for Revolution Medicines Inc. holders2025 Market Trends & Weekly Market Pulse Updates - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Will Revolution Medicines Inc. outperform the market2025 Biggest Moves & Weekly Watchlist for Hot Stocks - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

How sentiment analysis helps forecast Revolution Medicines Inc. Equity Warrant - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Measuring Revolution Medicines Inc. Equity Warrant’s beta against major indicesJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

How high can Revolution Medicines Inc. Equity Warrant stock go2025 Pullback Review & Capital Efficient Trade Techniques - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Full technical analysis of Revolution Medicines Inc. Equity Warrant stock - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Is now a turning point for Revolution Medicines Inc. Equity WarrantJobs Report & Technical Pattern Based Buy Signals - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Is Revolution Medicines Inc. Equity Warrant forming a reversal patternJuly 2025 WrapUp & Low Volatility Stock Suggestions - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

How analysts rate Revolution Medicines Inc. stock todayMarket Growth Review & Low Risk High Reward Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Revolution Medicines (RVMD) Stock Analysis: Unveiling a 56% Potential Upside Amidst Robust Buy Ratings - DirectorsTalk Interviews

Oct 13, 2025
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):